Literature DB >> 24953708

Academic drug discovery centres: the economic and organisational sustainability of an emerging model.

Henriette Schultz Kirkegaard1, Finn Valentin2.   

Abstract

Academic drug discovery centres (ADDCs) are seen as one of the solutions to fill the innovation gap in early drug discovery, which has proven challenging for previous organisational models. Prior studies of ADDCs have identified the need to analyse them from the angle of their economic and organisational sustainability. We take that angle in an in-depth study of four prominent ADDCs. Our findings indicate that there are clear similarities in the way sustainable centres are organised, managed and financed. We also identify factors in the frameworks of academia and research funding affecting their performance.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2014        PMID: 24953708     DOI: 10.1016/j.drudis.2014.06.011

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  5 in total

Review 1.  Novel Allosteric Modulators of G Protein-coupled Receptors.

Authors:  Patrick R Gentry; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

2.  Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.

Authors:  Maaike Everts; Mark J Suto; George R Painter; Richard J Whitley
Journal:  Future Virol       Date:  2016-02-29       Impact factor: 1.831

Review 3.  Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 4.  The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.

Authors:  Anna Karawajczyk; Kristina M Orrling; Jon S B de Vlieger; Ton Rijnders; Dimitrios Tzalis
Journal:  Front Med (Lausanne)       Date:  2017-01-19

5.  The endless frontier? The recent increase of R&D productivity in pharmaceuticals.

Authors:  Fabio Pammolli; Lorenzo Righetto; Sergio Abrignani; Luca Pani; Pier Giuseppe Pelicci; Emanuele Rabosio
Journal:  J Transl Med       Date:  2020-04-09       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.